Daiichi Sankyo: Business Plan - 5 Years (Daiichi Sankyo) - Apr 2, 2013 - Anticipated approval for multiple sclerosis in FY 2018; Anticipated launch for multiple sclerosis in FY 2018
Anticipated launch non-US • Anticipated non-US regulatory • Multiple Sclerosis
|